External Pacemaker Market Growth Statistics and Trend Analysis

 The growth of the global external pacemaker market is thriving on the back of the rising market penetration of key players along with the consequent entry of products in the market, and factors such as rising disposable income, favorable reimbursement policies, changing patient awareness regarding the early diagnosis of various chronic disorders such as coronary heart diseases, rheumatic heart diseases, congenital heart diseases, strokes and hypertension, and others are anticipated to promote the growth of the global external pacemaker market. Additionally, rising patient preference for products that are easy to set-up and manage over the recommended duration of cardiac pacing other products which improves their quality of life over the course of treatment especially during emergency care with patients suffering from irregular cardiac pacing are also anticipated to promote towards the growth of the global external pacemaker market.

The global external pacemaker market reached USD 899.15 million in the year 2018 and is expected to garner USD 1809.94 million by the end of 2028 by registering a CAGR of 7.22% across the globe over the forecast period 2021-2028. The market is further anticipated to gain an incremental $ opportunity of USD 70.63 million in the year 2020 as compared to the previous year. Further, the market is expected to gain an absolute $ opportunity of USD 698.58 million during the forecast period.

Growth Highlights based on Region during 2019-2028

The global external pacemaker market is segmented by regions into North America, Latin America, Europe, Asia Pacific and Middle East and Africa. Among these regions, the market of North America held the largest market share of 38.56% in the year 2019 and is expected to register a CAGR of 7.41% during the forecast period. Moreover, the market in the region is also anticipated to reach a value of USD 708.78 million by the end of 2028. On the other hand, the market in the region is also anticipated to gain an incremental $ opportunity of USD 27.82 million in the year 2020 as compared to the previous year. CLICK TO DOWNLOAD SAMPLE

Apparently, the market in Europe is anticipated to gain a significant market share and further grow by a CAGR of 6.78% during the forecast period on the back of the increasing prevalence of cardiovascular diseases in the region.

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Comments

Popular posts from this blog

Paraffin Inhibitors Market Future Insights and Global Trend Analysis

Advanced & Current Trends of Virtual Collaboration Market by 2029

Diesel Genset Market to be Driven by Surge in Concerns for Power Outages; Market to Grow with a CAGR of 6.50% During 2021-2030